VETOQUINOL EUR2.5 financial statements, including revenue, expenses, profit, and loss
The total revenue of 0O1O for the last semiannual is 273.06 M EUR, and it's 6.56% higher compared to the previous semiannual. The net income of H2 23 is 23.37 M EUR.